Alzac 20

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

49 Suppliers, 26 USDMF, 15 CEP/COS, 3 EU WC, 29 KDMF, 19 NDC API, 26 Listed Suppliers

DEVELOPMENTS

2 Drug(s) in Development

2 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

INTERMEDIATES

6 Suppliers

6 Suppliers

DOSSIERs // Finished Dosage Forms

440 Dossiers, 156 FDA Orange Book, 155 Europe, 45 Canada, 11 Australia, 22 South Africa, 51 Listed Dossiers

DRUG PRODUCT COMPOSITION

CAPSULE;ORAL - EQ 10MG BASE, CAPSULE;ORAL - EQ 20MG BASE, CAPSULE;ORAL - EQ 40MG BASE, TABLET;ORAL - EQ 60MG BASE, CAPSULE, DELAYED REL PELLETS;ORAL - EQ 90MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 15MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers, 33 Kerry, 32 BASF, 22 Roquette, 20 Microlex e.U, 17 SPI Pharma, 16 Seppic, 13 Gangwal Chemicals, 12 Sigachi Industries, 11 Gangwal Healthcare, 10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 10 Corel Pharma Chem, 9 Nanjing Well Pharmaceutical, 8 Actylis, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 7 Boai NKY Pharmaceuticals Ltd, 7 Ideal Cures Pvt Ltd, 6 Lonza Capsugel, 6 DFE Pharma, 5 Ingredion Pharma Solutions, 4 Vasa Pharmachem, 4 ACG Worldwide, 4 Kima Chemical, 4 Pharmatrans-Sanaq, 4 Prachin Chemical, 3 Ulanqab Kema New Material, 3 The Dow Chemical Company, 3 DKSH, 2 Pfanstiehl, 2 Jai Radhe Sales, 2 Nomisma Healthcare, 2 Qualicaps, 2 Rochem International Inc, 2 Seqens, 2 Finar, 1 Nanjing Bold Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Aeon Procare, 1 Clariant, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Evonik, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Alcedo Pharmachem, 1 Vertellus

EXCIPIENTS BY APPLICATIONS

84 Fillers, Diluents & Binders, 58 Coating Systems & Additives, 45 Disintegrants & Superdisintegrants, 45 Direct Compression, 33 Controlled & Modified Release, 32 Solubilizers, 31 Thickeners and Stabilizers, 29 Granulation, 21 Topical, 21 Parenteral, 21 Lubricants & Glidants, 20 Film Formers & Plasticizers, 20 Taste Masking, 17 Chewable & Orodispersible Aids, 16 Co-Processed Excipients, 9 Empty Capsules, 9 Emulsifying Agents, 8 API Stability Enhancers, 7 Rheology Modifiers, 6 Surfactant & Foaming Agents, 4 Vegetarian Capsules, 2 Coloring Agents

GLOBAL SALES INFORMATION

30 US Medicaid Prescriptions, 154 Finished Drug Prices

MARKET PLACE

19 APIs, 4 DOSSIERS // FDF

ANALYTICAL SOLUTION(s)

2 BioAnalytical Methods, 3 EDQM Standards, 3 USP Standards, 8 Other Ref. Standards

DIGITAL CONTENT

4 Data Compilation & Company Tracker #PharmaFlow, 53 News

Latest U.S. Prescription Data for Drugs containing Alzac 20 under Medicare's Part D Prescription Drug Program. Original Data: Centers for Medicare & Medicaid Services Website

Alzac 20

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

49 Suppliers

26 USDMF

15 CEP/COS

3 EU WC

29 KDMF

19 NDC API

26 Listed Suppliers

DEVELOPMENTS

2 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

FDF Imports

INTERMEDIATES

6 Suppliers

DOSSIERs // Finished Dosage Forms

440 Dossiers

156 FDA Orange Book

155 Europe

45 Canada

11 Australia

22 South Africa

51 Listed Dossiers

DRUG PRODUCT COMPOSITION

CAPSULE;ORAL - EQ 10MG BASE

CAPSULE;ORAL - EQ 20MG BASE

CAPSULE;ORAL - EQ 40MG BASE

TABLET;ORAL - EQ 60MG BASE

CAPSULE, DELAYED REL PELLETS;ORAL - EQ 90MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 15MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers

33 Kerry

32 BASF

22 Roquette

20 Microlex e.U

17 SPI Pharma

16 Seppic

13 Gangwal Chemicals

12 Sigachi Industries

11 Gangwal Healthcare

10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

10 Corel Pharma Chem

9 Nanjing Well Pharmaceutical

8 Actylis

7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

7 Boai NKY Pharmaceuticals Ltd

7 Ideal Cures Pvt Ltd

6 Lonza Capsugel

6 DFE Pharma

5 Ingredion Pharma Solutions

4 Vasa Pharmachem

4 ACG Worldwide

4 Kima Chemical

4 Pharmatrans-Sanaq

4 Prachin Chemical

3 Ulanqab Kema New Material

3 The Dow Chemical Company

3 DKSH

2 Pfanstiehl

2 Jai Radhe Sales

2 Nomisma Healthcare

2 Qualicaps

2 Rochem International Inc

2 Seqens

2 Finar

1 Nanjing Bold Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

1 Aeon Procare

1 Clariant

1 Shijiazhuang Huaxu Pharmaceutical

CAPSULE, DELAYED REL PELLETS;ORAL - EQ 90MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - EQ 10MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - EQ 15MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - EQ 20MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons